Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Cellectis S.A.
  6. News
  7. Summary
    ALCLS   FR0010425595

CELLECTIS S.A.

(ALCLS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Sharply Higher in Wednesday Trading

12/01/2021 | 11:08am EST


ę MT Newswires 2021
All news about CELLECTIS S.A.
01/21European ADRs Move Lower in Friday Trading
MT
01/20European ADRs Move Lower in Thursday Trading
MT
01/18Cellectis' Licensed Partner, Allogene Therapeutics, Announces Removal of FDA Clinical H..
AQ
01/13European ADRs Move Higher in Thursday Trading
MT
01/11Cellectis' Licensed Partner, Allogene Therapeutics, Announces Removal of FDA Clinical ..
AQ
01/11US FDA Lifts Hold on Cellectis Partner's Clinical Studies of Cancer Therapy
MT
01/10CELLECTIS S A : ' Licensed Partner, Allogene Therapeutics, Announces Removal of FDA Clinic..
PU
01/10Cellectis' Licensed Partner, Allogene Therapeutics,áAnnounces Removal of FDA Clinical H..
AQ
01/10Cellectis’ Licensed Partner, Allogene Therapeutics,áAnnounces Removal of FDA Clini..
CI
01/06European ADRs Move Higher in Thursday Trading
MT
More news
Analyst Recommendations on CELLECTIS S.A.
More recommendations
Financials
Sales 2021 55,0 M 62,2 M 62,2 M
Net income 2021 -122 M -137 M -137 M
Net cash 2021 74,4 M 84,1 M 84,1 M
P/E ratio 2021 -1,72x
Yield 2021 -
Capitalization 247 M 279 M 279 M
EV / Sales 2021 3,13x
EV / Sales 2022 1,94x
Nbr of Employees 277
Free-Float 84,4%
Chart CELLECTIS S.A.
Duration : Period :
Cellectis S.A. Technical Analysis Chart | ALCLS | FR0010425595 | MarketScreener
Technical analysis trends CELLECTIS S.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 5,42 €
Average target price 16,00 €
Spread / Average Target 195%
EPS Revisions
Managers and Directors
AndrÚ Choulika Chief Executive Officer & Director
Eric Dutang Chief Financial Officer
Jean-Pierre Garnier Non-Executive Chairman
Philippe Duchateau Chief Scientific Officer
Francisco J. Esteva Vice President-Clinical Development
Sector and Competitors
1st jan.Capi. (M$)
CELLECTIS S.A.-27.15%279
MODERNA, INC.-38.07%63 777
LONZA GROUP AG-19.59%49 711
IQVIA HOLDINGS INC.-13.62%46 556
SEAGEN INC.-16.20%23 689
ICON PUBLIC LIMITED COMPANY-17.32%20 842